Cargando…
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Mitogen-activated protein kinase (MAPK) pathway antagonists induce profound clinical responses in advanced cutaneous melanoma, but complete remissions are frustrated by the development of acquired resistance. Before resistance emerges, adaptive responses establish a mutation-independent drug toleran...
Autores principales: | Young, Helen L., Rowling, Emily J., Bugatti, Mattia, Giurisato, Emanuele, Luheshi, Nadia, Arozarena, Imanol, Acosta, Juan-Carlos, Kamarashev, Jivko, Frederick, Dennie T., Cooper, Zachary A., Reuben, Alexandre, Gil, Jesus, Flaherty, Keith T., Wargo, Jennifer A., Vermi, William, Smith, Michael P., Wellbrock, Claudia, Hurlstone, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460994/ https://www.ncbi.nlm.nih.gov/pubmed/28450382 http://dx.doi.org/10.1084/jem.20160855 |
Ejemplares similares
-
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
por: Smith, Michael P, et al.
Publicado: (2017) -
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
por: Filiberti, Serena, et al.
Publicado: (2022) -
Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
por: Chapman, Anna, et al.
Publicado: (2014) -
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
por: Smith, Michael P., et al.
Publicado: (2016) -
Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy
por: Wellbrock, Claudia, et al.
Publicado: (2015)